Chemotherapy and New Drugs in Prostate Cancer

Chemotherapy and New Drugs in Prostate Cancer

Bibliographic Details
Main Author:	Nicolas Mottet
Format:	Article
Language:	English
Published:	European Medical Journal 2015-05-01
Series:	European Medical Journal Urology
Online Access:	http://emjreviews.com/wp-content/uploads/Chemotherapy-and-New-Drugs-in-Prostate-Cancer.pdf

Similar Items

New drugs in prostate cancer
by: Sangjun Yoo, et al.
Published: (2016-06-01)

Role of chemotherapy in prostate cancer
by: Rita Nader, et al.
Published: (2018-01-01)

CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
by: Ya. V. Gridneva, et al.
Published: (2014-08-01)

CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
by: Ya. V. Gridneva, et al.
Published: (2014-08-01)

Chemotherapy options in castration-resistant prostate cancer
by: Benjamin A Teply, et al.
Published: (2016-01-01)

Ultrasound Therapy, Chemotherapy and Their Combination for Prostate Cancer
by: William Lopez MS, et al.
Published: (2021-05-01)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Vipin Lohiya, et al.
Published: (2016-01-01)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Vipin Lohiya, et al.
Published: (2016-10-01)

Prostate, benign hypertrophy and prostatic carcinoma - a study of cell biology of prostate and chemotherapy for prostatic hypertrophy and prostatic cancer /
by: Chang, Ching-Jey George
Published: (1994)

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
by: Yuji Miura, et al.
Published: (2019-03-01)

Current potentialities of chemotherapy for hormone-resistant cancer of the prostate
by: B. P. Matveyev, et al.
Published: (2020-02-01)

Efficiency of chemotherapy in the treatment of hormone-resistant prostate cancer
by: S. A. Kalinin
Published: (2020-02-01)

Development of chemotherapies for hormone-dependent breast and prostate cancers
by: Morrow, Michael Derek
Published: (2005)

Drug cocktail optimization in chemotherapy of cancer.
by: Saskia Preissner, et al.
Published: (2012-01-01)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
by: Anthony Van Baelen, et al.
Published: (2012-01-01)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
by: Prestwich Robin, et al.
Published: (2011-06-01)

Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
by: Niraj Shenoy, et al.
Published: (2016-01-01)

Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy
by: Benjamin A. Gartrell, et al.
Published: (2015-08-01)

Chemotherapy and its evolving role in the management of advanced prostate cancer
by: Michael T Schweizer, et al.
Published: (2014-06-01)

Chemotherapy for hormone-resistant prostate cancer: Where are we today?
by: Tomas Buchler, et al.
Published: (2007-01-01)

Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer
by: Yiwei Wang, et al.
Published: (2021-04-01)

Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem
by: B. Ya. Alekseev
Published: (2015-09-01)

Hormonal therapy and chemotherapy in patients with hormone-sensitive prostate cancer
by: R. A. Gafanov
Published: (2016-05-01)

The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
by: Sumit Agrawal
Published: (2020-01-01)

Antibody-Drug Conjugates: The New Frontier of Chemotherapy
by: Sara Ponziani, et al.
Published: (2020-07-01)

Side effects of drugs used in cancer chemotherapy
by: Oktawia Julia Pylak-Piwko, et al.
Published: (2017-11-01)

Targeting nanomaterials: future drugs for cancer chemotherapy
by: Zhang Y, et al.
Published: (2012-10-01)

Experimental Drugs for Chemotherapy- and Cancer-Related Anemia
by: Madeddu C, et al.
Published: (2021-06-01)

An evaluation of liposomes as drug carriers in cancer chemotherapy
by: Kaye, S. B.
Published: (1979)

Ailanthone: a new potential drug for castration-resistant prostate cancer
by: Shihong Peng, et al.
Published: (2017-03-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Mozaffar Aznab, et al.
Published: (2011-09-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Jamal Hoseini, et al.
Published: (2011-10-01)

Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
by: Jeanny B Aragon-Ching
Published: (2016-01-01)

miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
by: Prashanth K. B. Nagesh, et al.
Published: (2018-08-01)

Prostate-specific antigen testing in men with metastatic castration-resistant prostate cancer treated with docetaxel chemotherapy
by: Yuh-Shyan Tsai, et al.
Published: (2015-12-01)

Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy
by: Andreas Charalambous, et al.
Published: (2016-01-01)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
by: Jeremy P. Grummet, et al.
Published: (2021-09-01)

Intercalative drugs in cancer chemotherapy : two approaches towards drug development
by: Hartmann, Neil Godfried
Published: (1988)

Development of drugs for human prostate cancer /
by: Chen, Chiung-Tong
Published: (1997)

Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy
by: Milad Shamsi, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_qe8gkgmk9lpa4nslpnovt8hlft